CD20, AIF-1, and TGF-Β in graft-versus-host disease: A study of mRNA expression in histologically matched skin biopsies

Modern Pathology

Volumn 23, Issue 5, 2010, Pages 720-728

  Wu, Julie M ^a   Thoburn, Christopher J ^a   Wisell, Joshua ^a   Farmer, Evan R ^a   Hess, Allan D ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

AIF 1; CD20; Cytokines; Graft versus host disease; Skinbiopsy

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CD20 ANTIGEN; CD3 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LICHENOID; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SCLERODERMOID; SKIN BIOPSY; SKIN DISEASE; SURVIVAL RATE;

ANTIGENS, CD20; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; DNA-BINDING PROTEINS; GRAFT VS HOST DISEASE; HUMANS; RNA, MESSENGER; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77952008607     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.48     Document Type: Article

References (38)

1. Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008; 41 (Suppl 2) : S58-S64.
2. Hymes SR, Farmer ER, Lewis PG, et al. Cutaneous graft-versus-host reaction: prognostic features seen by light microscopy. J Am Acad Dermat 1985;12:468-474.
3. Darmstadt GL, Donnenberg AD, Vogelsang GB, et al. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease. J Invest Dermatol 1992;99:397-402.
4. Matsuoka LY. Graft versus host disease. J Am Acad Dermat 1981;5:595-599.
5. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versushost disease. Biol Blood Marrow Transplant 2003;9:215-233.
6. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol 2006;13:426-435.
7. Chen X, Vodanovic-Jankovic S, Johnson B, et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmunemediated pathology in chronic graft-versus-host disease. Blood 2007;110:3804-3813.
8. Miura Y, Thoburn CJ, Bright EC, et al. Association of Foxp3 regulatory gene expression with graft-versushost disease. Blood 2004;104:2187-2193.
9. Sarantopoulos S, Stevenson KE, Kim HT, et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 2007;13:6107-6114.
10. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006;108:756-762. (Pubitemid 44061381)
11. Zaja F, Bacigalupo A, Patriarca F, et al. Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant 2007;40:273-277.
12. Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003;9:505-511.
13. Rouquette-Gally AM, Boyeldieu D, Gluckman E, et al. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987;66:45-47.
14. Rouquette-Gally AM, Boyeldieu D, Prost AC, et al. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 1988;46:238-240.
15. Banovic T, MacDonald KP, Morris ES, et al. TGF-beta in allogeneic stem cell transplantation: friend or foe? Blood 2005;106:2206-2214.
16. Liem LM, Fibbe WE, van Houwelingen HC, et al. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999;67:59-65.
17. Kelemen SE, Autieri MV. Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am J Pathol 2005;167:619-626.
18. Utans U, Arceci RJ, Yamashita Y, et al. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995;95:2954-2962.
19. Utans U, Quist WC, McManus BM, et al. Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996;61:1387-1392.
20. del Galdo F, Maul GG, Jimenez SA, et al. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Arthritis Rheum 2006;54:2616-2625.
21. Tan FK, Zhou X, Mayes MD, et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006;45:694-702.
22. Ihn H. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008;49:103-113.
23. Ihn H, Yamane K, Kubo M, et al. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Arthritis Rheum 2001;44:474-480.
24. del Galdo F, Jimenez SA. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum 2007;56:3478-3488.
25. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-476.
26. Cools N, Ponsaerts P, Van Tendeloo VF, et al. Regulatory T cells and human disease. Clin Dev Immunol 2007;2007:89195.
27. Fujita S, Sato Y, Sato K, et al. Regulatory dendritic cells protect against cutaneous chronic graft-versushost disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Blood 2007;110:3793-3803.
28. Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996;106:729-733.
29. Igarashi A, Nashiro K, Kikuchi K, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermat 1995;105:280-284.
30. Aliprantis AO, Wang J, Fathman JW, et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci USA 2007;104:2827-2830.
31. Ochs LA, Blazar BR, Roy J, et al. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant 1996;17:1085-1092.
32. Ritchie D, Seconi J, Wood C, et al. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:706-712.
33. Imamura M, Hashino S, Kobayashi H, et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferongamma, and tumor necrosis factor-alpha in graftversus-host disease. Bone Marrow Transplant 1994;13:745-751. (Pubitemid 24195790)
34. Barak V, Levi-Schaffer F, Nisman B, et al. Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 1995;17:169-173.
35. Greenbaum D, Colangelo C, Williams K, et al. Comparing protein abundance and MRNA expression levels on a genomic scale. Genome Biol 2003;4:117.
36. Jansen R, Greenbaum D, Gerstein M. Relating wholegenome expression data with protein-protein interactions. Genome Res 2002;12:37-46.
37. Shakir R, Ngo N, Naresh KN. Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma. J Clin Pathol 2008;61:920-927.
38. Capriotti E, Vonderheid EC, Thoburn CJ, et al. Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 2008;49:1190-1201.